Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 14, 2018

View Archived Issues

Disconnecting bone building from resorption may be osteoporosis strategy

Myocardial regeneration outcomes using WJMSCs presented from pilot cohort of CIRCULATE-AMI study

Identification of a mosquito salivary gland protein that partially limits malaria transmission

MPO-0112 ameliorates scopolamine-induced cognitive impairment in mice

Ozalin becomes the first oral pediatric sedative to receive marketing authorization in Europe

BioArctic enters research collaboration with Brain Biomarker Solutions in Alzheimer's

New sphingolipid-biased phenotypic approach for the discovery of new targets and new leads

XBiotech presents positive interim data for initial cohort of bermekimab pilot study

FDA approves subcutaneous Actemra for active systemic juvenile idiopathic arthritis

Bone Therapeutics reports final data from phase I/IIa study of ALLOB in delayed-union fractures

Merck & Co. evaluating MK-1654 in phase I/II study in healthy preterm and full-term infants

FDA approves Lumoxiti for relapsed or refractory hairy cell leukemia

Patient recruitment ongoing in phase I study of INCAGN-02390

TD-1473 being evaluated in phase II study in patients with active Crohn's disease

Natera enters agreement with Bristol-Myers Squibb for use of Signatera ctDNA assay in Opdivo trial

Biogen begins clinical evaluation of BIIB-078 in C9ORF72-associated ALS

Arrowhead Pharmaceuticals patents RNAi for thromboembolic disorders

GSK begins first-in-human study of GSK-3439171A

Hanyang University presents new MAPK 10 inhibitors

Merck & Co. synthesizes new IDO1 inhibitors

Monash University and GSK present discovery of novel compound for treatment of Chagas disease

NTZ-2020 and NTZ-2027 as promising new candidates for the treatment and diagnosis of CNS disease

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...